| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/2003 | US6548639 IgG-binding protein from Staphylococcus and nucleotide sequence encoding this protein |
| 04/15/2003 | US6548635 Protein or polypeptide that binds with an antibody that binds to a polypeptide of the specific amino acid sequence; for diagnosis and the preparation of vaccines |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548295 Complex of lipo-viro-particles, method of preparation and applications |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548273 lacR from Streptococcus pneumoniae |
| 04/15/2003 | US6548070 Attenuated strains of mycobacteria |
| 04/15/2003 | US6548069 Multivalent Mycoplasma bacterin |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/15/2003 | US6548066 Inducing antibodies; antitumor agent |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | US6548061 Repair central nervous system damage; kit containing complement fixing antibodies |
| 04/15/2003 | CA2059979C Complex containing coagulation factor ix |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/10/2003 | WO2003029488A2 A method for the early detection of cancer |
| 04/10/2003 | WO2003029484A2 Antimicrobial methods and materials |
| 04/10/2003 | WO2003029475A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND β2m AND UTILIZATION THEREOF |
| 04/10/2003 | WO2003029460A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 04/10/2003 | WO2003029451A2 Histone deacetylase 9 |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029434A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029427A2 Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2 |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029295A1 Human tissue factor antibodies |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029289A2 Fragements of heat shock proteins and their use |
| 04/10/2003 | WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | WO2003029285A2 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 04/10/2003 | WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/10/2003 | WO2003028760A2 Vaccine |
| 04/10/2003 | WO2003028759A1 Rsv gene expression vaccine |
| 04/10/2003 | WO2003028758A1 Novel method of inducing antigen-specific t cells |
| 04/10/2003 | WO2003028757A1 Novel method of inducing antigen-specific t cells |
| 04/10/2003 | WO2003028722A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 04/10/2003 | WO2003028668A2 Gammaglobulin treatment of immune disorders |
| 04/10/2003 | WO2003028661A2 Adjuvanted meningococcus compositions |
| 04/10/2003 | WO2003028656A2 Adjuvant compositions |
| 04/10/2003 | WO2003028638A2 Treatment of uterine serous papillary cancer |
| 04/10/2003 | WO2003028634A2 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | WO2003028632A2 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | WO2003028543A2 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 04/10/2003 | WO2003028441A1 Gene therapy for the prevention of autoimmune disease |
| 04/10/2003 | WO2003017935A9 Human antibodies specific for interleukin 15 (il-15) |
| 04/10/2003 | WO2003014326A3 Isolation and mobilization of stem cells expressing vegfr-1 |
| 04/10/2003 | WO2003007971A9 Improved heteropolymer complexes and methods for their use |
| 04/10/2003 | WO2003006607A9 Inhibition of apoptosis process and improvement of cell performance |
| 04/10/2003 | WO2003006056A3 End-locked five-helix protein |
| 04/10/2003 | WO2003002598A3 Peptides for use as translocation factors |
| 04/10/2003 | WO2002101019A3 Methods of culturing animal cells and polypeptide production in animal cells |
| 04/10/2003 | WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 04/10/2003 | WO2002094184A3 Vaccines for the treatment of autoimmune disease |
| 04/10/2003 | WO2002090510A3 Regulating immine responses using dendritic cells |
| 04/10/2003 | WO2002087502A3 Antibodies abolish prion propagation and promote clearance of infectivity |
| 04/10/2003 | WO2002083079A9 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 04/10/2003 | WO2002081704A3 Regulation of human protein kinase-like protein |
| 04/10/2003 | WO2002081504A3 Multimerization of hiv-1 vif protein as a therapeutic target |
| 04/10/2003 | WO2002080982A9 Nucleic acid mucosal immunization |
| 04/10/2003 | WO2002078735A3 Leishmania vaccines |
| 04/10/2003 | WO2002068602A8 Methods for modulating g2a receptor activity |
| 04/10/2003 | WO2002062383A3 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases |
| 04/10/2003 | WO2002060412A3 Stabilised polymeric aerosols for pulmonary gene delivery |
| 04/10/2003 | WO2002055705A3 Proteins and nucleic acids encoding same |
| 04/10/2003 | WO2002050122A3 Means for the diagnosis and therapy of ctcl |
| 04/10/2003 | WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments |
| 04/10/2003 | WO2002033058A3 Novel cysteine proteases and uses thereof |
| 04/10/2003 | WO2002028889A3 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/10/2003 | WO2002012294A3 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 04/10/2003 | WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/10/2003 | WO2001092547A9 Modified bovine adenovirus having altered tropism |
| 04/10/2003 | WO2001058480A3 Tubulin based vaccine against trypanosomiasis |
| 04/10/2003 | US20030070185 Animal model for use in the generation of preferential antibodies |
| 04/10/2003 | US20030070184 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof |
| 04/10/2003 | US20030069404 Nucleotide sequences coding polypeptide for use in the prevention and treatment of microorganismal infections |
| 04/10/2003 | US20030069315 New use for 1,3-propanediol derivatives |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 04/10/2003 | US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 04/10/2003 | US20030069180 Compositions and methods for the therapy and diagnosis of colon cancer |
| 04/10/2003 | US20030069179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068812 Immune modulation device for use in animals |
| 04/10/2003 | US20030068690 Process for the in vitro culture of different stages of tissular parasites |
| 04/10/2003 | US20030068678 WISP polypeptides and nucleic acids encoding same |
| 04/10/2003 | US20030068671 Polypeptide for use in the prevention, treatment and diagnosis of infections, eating, nervous system, blood, immunological and diabetic disorders |
| 04/10/2003 | US20030068664 Monitoring effectiveness of preferential cancer immunotherapy; obtain mammal, administer immunotherapy, evaluate effectiveness of treatment |
| 04/10/2003 | US20030068659 ICAM-4 materials and methods |
| 04/10/2003 | US20030068363 Complexes consisting of an isolated major histocompatibility complex component and an autoantigenic peptide associated with the antigen binding site of the component; useful in treating autoimmune disease |
| 04/10/2003 | US20030068360 DNA vaccines for farm animals, in particular bovines and porcines |
| 04/10/2003 | US20030068337 Composition comprising tumor cells and extracts and method using thereof |
| 04/10/2003 | US20030068336 Purified capsular polysaccharides from Neisseria meningitidis serogroups are activated and attached to a carriers protein |
| 04/10/2003 | US20030068334 IBDV strain for in ovo administration |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068328 Live attenuated salmonella strains for producing monovalent or multivalent vaccines |
| 04/10/2003 | US20030068327 Compositions and methods for the diagnosis and threatment of herpes simplex virus infection |
| 04/10/2003 | US20030068326 Method for the treatment of gastroesophageal reflux disease |
| 04/10/2003 | US20030068325 A peptide immunogen of about 20 to 100 amino acids long comprising: a helper T cell (Th) epitope, an N-terminal fragment of A beta 1-42 peptide, consisting from 10-28 amino acid residues |
| 04/10/2003 | US20030068320 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| 04/10/2003 | US20030068318 Administering to a uterine serous papillary carcinoma patient a therapeutically effective dose of a HER-2/neu (human epidermal growth factor receptor-2) antibody. |